| Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach F Del Chierico, V Nobili, P Vernocchi, A Russo, C De Stefanis, D Gnani, ... Hepatology 65 (2), 451-464, 2017 | 625 | 2017 |
| Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ... Hepatology 61 (2), 506-514, 2015 | 559 | 2015 |
| Randomised clinical trial: the beneficial effects of VSL# 3 in obese children with non‐alcoholic steatohepatitis A Alisi, G Bedogni, G Baviera, V Giorgio, E Porro, C Paris, P Giammaria, ... Alimentary pharmacology & therapeutics 39 (11), 1276-1285, 2014 | 504 | 2014 |
| Complications, morbidity and mortality of nonalcoholic fatty liver disease A Mantovani, E Scorletti, A Mosca, A Alisi, CD Byrne, G Targher Metabolism 111, 154170, 2020 | 393 | 2020 |
| I148M patatin‐like phospholipase domain‐containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease L Valenti, A Alisi, E Galmozzi, A Bartuli, B Del Menico, A Alterio, ... Hepatology 52 (4), 1274-1280, 2010 | 323 | 2010 |
| Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial V Nobili, G Bedogni, A Alisi, A Pietrobattista, P Risé, C Galli, C Agostoni Archives of disease in childhood 96 (4), 350-353, 2011 | 321 | 2011 |
| Antioxidant effects of natural bioactive compounds C Balsano, A Alisi Current pharmaceutical design 15 (26), 3063-3073, 2009 | 264 | 2009 |
| NAFLD in children: new genes, new diagnostic modalities and new drugs V Nobili, A Alisi, L Valenti, L Miele, AE Feldstein, N Alkhouri Nature reviews Gastroenterology & hepatology 16 (9), 517-530, 2019 | 250 | 2019 |
| Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review. V Nobili, A Alisi, N Panera, C Agostoni Pediatric endocrinology reviews: PER 6 (2), 241-247, 2008 | 230 | 2008 |
| Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores C Bianco, O Jamialahmadi, S Pelusi, G Baselli, P Dongiovanni, I Zanoni, ... Journal of hepatology 74 (4), 775-782, 2021 | 228 | 2021 |
| Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease A Alisi, L Da Sacco, G Bruscalupi, F Piemonte, N Panera, R De Vito, ... Laboratory investigation 91 (2), 283-293, 2011 | 226 | 2011 |
| Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cells via microRNA targeting peroxisome proliferator-activated receptor-γ D Povero, N Panera, A Eguchi, CD Johnson, BG Papouchado, ... Cellular and molecular gastroenterology and hepatology 1 (6), 646-663. e4, 2015 | 204 | 2015 |
| A 360-degree overview of paediatric NAFLD: recent insights V Nobili, G Svegliati-Baroni, A Alisi, L Miele, L Valenti, P Vajro Journal of hepatology 58 (6), 1218-1229, 2013 | 203 | 2013 |
| Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children V Nobili, A Alisi, C Della Corte, P Risé, C Galli, C Agostoni, G Bedogni Nutrition, Metabolism and Cardiovascular Diseases 23 (11), 1066-1070, 2013 | 196 | 2013 |
| Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity V Giorgio, L Miele, L Principessa, F Ferretti, MP Villa, V Negro, A Grieco, ... Digestive and Liver Disease 46 (6), 556-560, 2014 | 187 | 2014 |
| Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents A Mosca, V Nobili, R De Vito, A Crudele, E Scorletti, A Villani, A Alisi, ... Journal of hepatology 66 (5), 1031-1036, 2017 | 177 | 2017 |
| The role of tissue macrophage-mediated inflammation on NAFLD pathogenesis and its clinical implications A Alisi, G Carpino, FL Oliveira, N Panera, V Nobili, E Gaudio Mediators of inflammation 2017, 2017 | 176 | 2017 |
| The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease V Nobili, A Alisi, A Vania, C Tiribelli, A Pietrobattista, G Bedogni BMC medicine 7, 1-7, 2009 | 176 | 2009 |
| Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease V Nobili, G Carpino, A Alisi, A Franchitto, G Alpini, R De Vito, P Onori, ... Hepatology 56 (6), 2142-2153, 2012 | 175 | 2012 |
| Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study V Nobili, M Manco, P Ciampalini, A Alisi, R Devito, E Bugianesi, ... Clinical therapeutics 30 (6), 1168-1176, 2008 | 175 | 2008 |
